Nexovas TC 40mg/10mg/12.5mg Tablet
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)
Overview Nexovas TC 40mg/10mg/12.5mg Tablet
Trivasal-40/10/12.5mg tablets combine multiple medications to manage hypertension when monotherapy proves insufficient. This formulation effectively reduces elevated blood pressure, thereby mitigating the risk of future cardiovascular events such as stroke and heart attack. Administer Trivasal-40/10/12.5mg tablets with food, adhering to the prescribed dosage regimen tailored to your individual needs and response. Maintain consistent daily timing. Continuous use, as directed by your physician, is crucial. The medication includes a diuretic, increasing urinary frequency; therefore, avoid ingestion within four hours of bedtime. Regular use, even during asymptomatic periods, maximizes therapeutic benefits. Discontinuing treatment elevates the risk of stroke or heart attack. Common adverse effects may encompass ankle edema, cephalalgia, vertigo, fatigue, and altered taste perception. Report any persistent, worsening, or intolerable side effects to your doctor promptly. Maintain adequate hydration to mitigate potential symptoms like myalgia, xerostomia, and polydipsia. Prior to initiating treatment, disclose any pre-existing hepatic or renal impairment. Pregnant or lactating individuals should seek medical counsel before use. Comprehensive disclosure of all concurrent medications, particularly those for hypertension or cardiac conditions, is essential. Regular monitoring of blood pressure, renal function, electrolyte levels, and glycemia is necessary to optimize treatment efficacy and safety.
Primary Ingredients of Nexovas TC 40mg/10mg/12.5mg Tablet
No text provided to rephrase.
Uses of Nexovas TC 40mg/10mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Nexovas TC 40mg/10mg/12.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nexovas TC 40mg/10mg/12.5mg tablets should be administered with a meal.
Common Side effects of Nexovas TC 40mg/10mg/12.5mg Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Increased blood uric acid
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Nexovas TC 40mg/10mg/12.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Nexovas TC 40mg/10mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.
How Nexovas TC 40mg/10mg/12.5mg Tablet works:
Nexovas TC tablets (40mg/10mg/12.5mg) combine telmisartan, cilnidipine, and chlorthalidone to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and cilnidipine, a dihydropyridine calcium channel blocker, both promote vasodilation, reducing blood pressure. Chlorthalidone, a thiazide diuretic, lowers blood pressure by increasing urinary excretion of sodium and water, contributing to vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Nexovas TC 40mg/10mg/12.5mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Employing Nexovas TC 40mg/10mg/12.5mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Medical consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Nexovas TC 40mg/10mg/12.5mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, visual disturbances, or dizziness after taking Nexovas TC 40mg/10mg/12.5mg tablets, as these side effects may impair alertness.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Nexovas TC 40mg/10mg/12.5mg tablets, as dose modification may be necessary. A physician's consultation is advised; administration is generally discouraged in such cases.
LiverCAUTION
Patients with liver impairment should use Nexovas TC 40mg/10mg/12.5mg tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Nexovas TC 40mg/10mg/12.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Nexovas TC 40mg/10mg/12.5mg Tablet :
Should you forget a Nexovas TC 40mg/10mg/12.5mg Tablet dose, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nexovas TC 40mg/10mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |






